This topic contains a solution. Click here to go to the answer

Author Question: In early 2002, President __________ made his famous axis of evil speech, which inflamed American ... (Read 43 times)

tth

  • Hero Member
  • *****
  • Posts: 579

Question 1

By early 2008, the American death toll in Iraq had surpassed __________ people.
 
  Fill in the blank(s) with the appropriate word(s).

Question 2

The war against _______________did not receive United Nations support when it began in 2003.
 
  Fill in the blank(s) with the appropriate word(s).

Question 3

In early 2002, President __________ made his famous axis of evil speech, which inflamed American relations with the Muslim world.
 
  Fill in the blank(s) with the appropriate word(s).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

moormoney

  • Sr. Member
  • ****
  • Posts: 326

Answer 1

Answer: 4,000

Answer 2

Answer: Iraq

Answer 3

Answer: George W. Bush



tth

  • Hero Member
  • *****
  • Posts: 579
Both answers were spot on, thank you once again




 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library